| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $65.2M | +54.4% |
| SG&A Expense | $19.8M | +9.4% |
| Operating Income | -$85.0M | -41.0% |
| Pre-tax Income | -$76.3M | -29.8% |
| Income Tax | $137K | — |
| Net Income | -$76.4M | -30.0% |
| EPS (Basic) | -$1.93 | +1.5% |
| EPS (Diluted) | -$1.93 | +1.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.1M | -66.2% |
| Current Assets | $231.8M | +17.8% |
| Total Assets | $255.1M | +13.9% |
| Current Liabilities | $12.4M | +18.2% |
| Total Liabilities | $29.2M | +3.1% |
| Stockholders' Equity | $225.8M | +15.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$63.8M | -16.9% |
| Capital Expenditures | $709K | -35.2% |
| Investing Cash Flow | -$114.0M | -67.9% |
| Financing Cash Flow | $97.3M | +1.7% |
| Free Cash Flow | -$64.6M | -15.9% |